GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
Top Cited Papers
Open Access
- 1 December 2014
- journal article
- research article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 64 (6), 821-835
- https://doi.org/10.1053/j.ajkd.2014.07.030
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysisBMJ, 2013
- Age and Association of Kidney Measures With Mortality and End-stage Renal DiseaseJAMA, 2012
- Acute kidney injuryThe Lancet, 2012
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin CThe New England Journal of Medicine, 2012
- Longitudinal Progression Trajectory of GFR Among Patients With CKDAmerican Journal of Kidney Diseases, 2012
- National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2011: Executive SummaryAmerican Journal of Kidney Diseases, 2012
- Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohortsKidney International, 2011
- Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled datasetNephrology Dialysis Transplantation, 2010
- Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysisThe Lancet, 2010
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001